Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 189.1 SEK 1.1% Market Closed
Market Cap: 51.5B SEK
Have any thoughts about
Getinge AB?
Write Note

Getinge AB
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Getinge AB
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Getinge AB
STO:GETI B
Pre-Tax Income
kr3.3B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Pre-Tax Income
kr1.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Pre-Tax Income
kr237.1m
CAGR 3-Years
137%
CAGR 5-Years
104%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Pre-Tax Income
kr188.7m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
16%
Arjo AB (publ)
STO:ARJO B
Pre-Tax Income
kr640m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Pre-Tax Income
kr61.2m
CAGR 3-Years
42%
CAGR 5-Years
15%
CAGR 10-Years
47%
No Stocks Found

Getinge AB
Glance View

Market Cap
51.5B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
278.42 SEK
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Getinge AB's Pre-Tax Income?
Pre-Tax Income
3.3B SEK

Based on the financial report for Dec 31, 2023, Getinge AB's Pre-Tax Income amounts to 3.3B SEK.

What is Getinge AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
-9%

Over the last year, the Pre-Tax Income growth was -4%. The average annual Pre-Tax Income growth rates for Getinge AB have been -9% over the past three years .

Back to Top